Dermal fibroblasts genetically modified to express Runx2/Cbfa1 as a mineralizing cell source for bone tissue engineering

Tissue Engineering

Volumn 13, Issue 8, 2007, Pages 2029-2040

  Phillips, Jennifer E ^a,b   Guldberg, Robert E ^b,c   García, Andrés J ^b,c  

^a Emory University   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; BONE; HYDROXYAPATITE; IMPLANTS (SURGICAL); TISSUE ENGINEERING;

BIOLOGICALLY-EQUIVALENT MINERAL; BONE TISSUE ENGINEERING; DERMAL FIBROBLASTS;

FIBROBLASTS;

HYDROXYAPATITE; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE TISSUE; CONTROLLED STUDY; DERMIS; IMMUNOHISTOCHEMISTRY; MALE; MINERALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKIN FIBROBLAST; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BONE SUBSTITUTES; CALCIFICATION, PHYSIOLOGIC; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DERMIS; FIBROBLASTS; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; MALE; MICE; RATS; RATS, WISTAR; TISSUE ENGINEERING; TRANSFECTION;

EID: 34548067391     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0041     Document Type: Article

References (74)

1. Bucholz, R.W. Nonallograft osteoconductive bone graft substitutes. Clin. Orthop. Relat. Res. 44, 2002.
2. Vaccaro, A.R. The role of the osteoconductive scaffold in synthetic bone graft. Orthopedics 25, S571, 2002.
3. Finkemeier, C.G. Bone-grafting and bone-graft substitutes. J. Bone Joint Surg. Am. 84-A, 454, 2002.
4. Khan, S.N., Tomin, E., and Lane, J.M. Clinical applications of bone graft substitutes. Orthop. Clin. North Am. 31, 389, 2000.
5. Perry, C.R. Bone repair techniques, bone graft, and bone graft substitutes. Clin. Orthop. Relat. Res. 71, 1999.
6. Friedlaender, G.E., Perry, C.R., Cole, J.D., Cook, S.D., Cierny, G., Muschler, G.F., Zych, G.A., Calhoun, J.H., LaForte, A.J., and Yin, S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Joint Surg. Am. 83-A Suppl 1, S151, 2001.
7. Johnson, E.E., Urist, M.R., and Finerman, G.A. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin. Orthop. Relat Res. 257, 1988.
8. Uludag, H., Gao, T., Porter, T.J., Friess, W., and Wozney, J.M. Delivery systems for BMPs: factors contributing to protein retention at an application site. J. Bone Joint Surg. Am. 83-A Suppl 1, S128, 2001.
9. Wozney, J.M. Overview of bone morphogenetic proteins. Spine 27, S2, 2002.
10. Bruder, S.P. and Fox, B.S. Tissue engineering of bone. Cell based strategies. Clin. Orthop. Relat Res. S68, 1999.
11. Mistry, A.S. and Mikos, A.G. Tissue engineering strategies for bone regeneration. Adv. Biochem. Eng. Biotechnol. 94, 1, 2005.
12. Salgado, A.J., Coutinho, O.P., and Reis, R.L. Bone tissue engineering: state of the art and future trends. Macromol. Biosci. 4, 743, 2004.
13. Doll, B., Sfeir, C., Winn, S., Huard, J., and Hollinger, J. Critical aspects of tissue-engineered therapy for bone regeneration. Crit. Rev. Eukaryot. Gene Expr. 11, 173, 2001.
14. Ishaug-Riley, S.L., Crane-Kruger, G.M., Yaszemski, M.J., and Mikos, A.G. Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials 19, 1405, 1998.
15. Yamanouchi, K., Satomura, K., Gotoh, Y., Kitaoka, E., Tobiume, S., Kume, K., and Nagayama, M. Bone formation by transplanted human osteoblasts cultured within collagen sponge with dexamethasone in vitro. J. Bone Miner. Res. 16, 857, 2001.
16. Salgado, A.J., Coutinho, O.P., and Reis, R.L. Novel starch-based scaffolds for bone tissue engineering: cytotoxicity, cell culture, and protein expression. Tissue Eng. 10, 465, 2004.
17. Shea, L.D., Wang, D., Franceschi, R.T., and Mooney, D.J. Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng. 6, 605, 2000.
18. Grundel, R.E., Chapman, M.W., Yee, T., and Moore, D.C. Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clin. Orthop. Relat. Res. 244, 1991.
19. Ohgushi, H., Goldberg, V.M., and Caplan, A.I. Heterotopic osteogenesis in porous ceramics induced by marrow cells. J. Orthop. Res. 7, 568, 1989.
20. Horwitz, E.M., Gordon, P.L., Koo, W.K., Marx, J.C., Neel, M.D., McNall, R.Y., Muul, L., and Hofmann, T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc. Natl. Acad. Sci. U. S. A. 99, 8932, 2002.
21. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
22. Mauney, J.R., Volloch, V., and Kaplan, D.L. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11, 787, 2005.
23. Kon, E., Muraglia, A., Corsi, A., Bianco, P., Marcacci, M., Martin, I., Boyde, A., Ruspantini, I., Chistolini, P., Rocca, M., Giardino, R., Cancedda, R., and Quarto, R. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J. Biomed. Mater. Res. 49, 328, 2000.
24. Ohgushi, H., Goldberg, V.M., and Caplan, A.I. Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop. Scand. 60, 334, 1989.
25. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S.M., Mukhachev, V., Lavroukov, A., Kon, E., and Marcacci, M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 344, 385, 2001.
26. Bruder, S.P., Fink, D.J., and Caplan, A.I. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J. Cell Biochem. 56, 283, 1994.
27. Arinzeh, T.L., Peter, S.J., Archambault, M.P., van den, B.C., Gordon, S., Kraus, K., Smith, A., and Kadiyala, S. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J. Bone Joint Surg. Am. 85-A, 1927, 2003.
28. Haynesworth, S.E., Goshima, J., Goldberg, V.M., and Caplan, A.I. Characterization of cells with osteogenic potential from human marrow. Bone 13, 81, 1992.
29. Bruder, S.P. and Fox, B.S. Tissue engineering of bone. Cell based strategies. Clin. Orthop. Relat. Res. S68, 1999.
30. Kahn, A., Gibbons, R., Perkins, S., and Gazit, D. Age-related bone loss. A hypothesis and initial assessment in mice. Clin. Orthop. Relat. Res. 69, 1995.
31. Quarto, R., Thomas, D., and Liang, C.T. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif. Tissue Int. 56, 123, 1995.
32. Franceschi, R.T., Yang, S., Rutherford, R.B., Krebsbach, P.H., Zhao, M., and Wang, D. Gene therapy approaches for bone regeneration. Cells Tissues Organs 176, 95, 2004.
33. Rutherford, R.B., Moalli, M., Franceschi, R.T., Wang, D., Gu, K., and Krebsbach, P.H. Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng. 8, 441, 2002.
34. Zhao, M., Zhao, Z., Koh, J.T., Jin, T., and Franceschi, R.T. Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J. Cell Biochem. 95, 1, 2005.
35. Yang, S., Wei, D., Wang, D., Phimphilai, M., Krebsbach, P.H., and Franceschi, R.T. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J. Bone Miner. Res. 18, 705, 2003.
36. Hirata, K., Tsukazaki, T., Kadowaki, A., Furukawa, K., Shibata, Y., Moriishi, T., Okubo, Y., Bessho, K., Komori, T., Mizuno, A., and Yamaguchi, A. Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2. Bone 32, 502, 2003.
37. Krebsbach, P.H., Gu, K., Franceschi, R.T., and Rutherford, R.B. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum. Gene Ther. 11, 1201, 2000.
38. Wozney, J.M. and Seeherman, H.J. Protein-based tissue engineering in bone and cartilage repair. Curr. Opin. Biotechnol. 15, 392, 2004.
39. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747, 1997.
40. Karsenty, G., Ducy, P., Starbuck, M., Priemel, M., Shen, J., Geoffroy, V., and Amling, M. Cbfa1 as a regulator of osteoblast differentiation and function. Bone 25, 107, 1999.
41. Franceschi, R.T. and Xiao, G. Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J. Cell Biochem. 88, 446, 2003.
42. Franceschi, R.T. Functional cooperativity between osteoblast transcription factors: evidence for the importance of subnuclear macromolecular complexes? Calcif. Tissue Int. 72, 638, 2003.
43. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R.T., Gao, Y.H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S., and Kishimoto, T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755, 1997.
44. Byers, B.A., Pavlath, G.K., Murphy, T.J., Karsenty, G., and Garcia, A.J. Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfa1. J. Bone Miner. Res. 17, 1931, 2002.
45. Byers, B.A. and Garcia, A.J. Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells. Tissue Eng. 10, 1623, 2004.
46. Zheng, H., Guo, Z., Ma, Q., Jia, H., and Dang, G. Cbfa1/osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo. Calcif. Tissue Int. 74, 194, 2004.
47. Zhao, Z., Zhao, M., Xiao, G., and Franceschi, R.T. Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol. Ther. 12, 247, 2005.
48. Gersbach, C.A., Byers, B.A., Pavlath, G.K., Guldberg, R.E., and Garcia, A.J. Runx2/Cbfa1-genetically engineered skeletal myoblasts mineralize collagen scaffolds in vitro. Biotechnol. Bioeng. 88, 369, 2004.
49. Gersbach, C.A., Le Doux, J.M., Guldberg, R.E., and Garcia, A.J. Inducible regulation of Runx2-stimulated osteogenesis. Gene Ther. 2006.
50. Phillips, J.E., Gersbach, C.A., Wojtowicz, A.M., and Garcia, A.J. Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J. Cell Sci. 119, 581, 2006.
51. Weinberg, W.C., Goodman, L.V., George, C., Morgan, D.L., Ledbetter, S., Yuspa, S.H., and Lichti, U. Reconstitution of hair follicle development in vivo - determination of follicle formation, hair-growth, and hair quality by dermal cells. J. Invest. Dermatol. 100, 229, 1993.
52. Banerjee, C., Javed, A., Choi, J.Y., Green, J., Rosen, V., Van Wijnen, A.J., Stein, J.L., Lian, J.B., and Stein, G.S. Differential regulation of the two principal Runx2/Cbfa1 N-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142, 4026, 2001.
53. Harada, H., Tagashira, S., Fujiwara, M., Ogawa, S., Katsumata, T., Yamaguchi, A., Komori, T., and Nakatsuka, M. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J. Biol. Chem. 274, 6972, 1999.
54. Hildebrand, T., Laib, A., Muller, R., Dequeker, J., and Ruegsegger, P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J. Bone Miner. Res. 14, 1167, 1999.
55. Byers, B.A., Guldberg, R.E., and Garcia, A.J. Synergy between genetic and tissue engineering: Runx2 overexpression and in vitro construct development enhance in vivo mineralization. Tissue Eng. 10, 1757, 2004.
56. Seibel, M.J. Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos. Int. 11 Suppl 6, S18, 2000.
57. Ducy, P., Boyce, B.F., Story, B., Dunstan, C., and Karsenty, G. Increased bone formation in osteocalcin-deficient mice without bone resorption defect. J. Bone Min.1 Res. 11, 43, 1996.
58. Bonewald, L.F., Harris, S.E., Rosser, J., Dallas, M.R., Dallas, S.L., Camacho, N.P., Boyan, B., and Boskey, A. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif. Tissue Int. 72, 537, 2003.
59. Bonewald, L.F., Dallas, S., Qiao, M., Camacho, N.P., Boyan, B., and Boskey, A. Comparison of mineralized matrix of fetal rat calvarial cells and MC-3T3-E1 osteoblast-like cells by Fourier transform infrared spectroscopy (FT-IR). J. Bone Min. Res. 11, S333, 1996.
60. Sauer, G.R. and Wuthier, R.E. Fourier transform infrared characterization of mineral phases formed during induction of mineralization by collagenase-released matrix vesicles in vitro. J. Biol. Chem. 263, 13718, 1988.
61. Glowacki, J., Mizuno, S., and Greenberger, J.S. Perfusion enhances functions of bone marrow stromal cells in three-dimensional culture. Cell Transplant. 7, 319, 1998.
62. Mueller, S.M., Mizuno, S., Gerstenfeld, L.C., and Glowacki, J. Medium perfusion enhances osteogenesis by murine osteosarcoma cells in three-dimensional collagen sponges. J. Bone Miner. Res. 14, 2118, 1999.
63. Mauney, J.R., Volloch, V., and Kaplan, D.L. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng. 11, 787, 2005.
64. Termaat, M.F., Den Boer, F.C., Bakker, F.C., Patka, P., and Haarman, H.J. Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects. J. Bone Joint Surg. Am. 87, 1367, 2005.
65. Wozney, J.M. and Seeherman, H.J. Protein-based tissue engineering in bone and cartilage repair. Curr. Opin. Biotechnol. 15, 392, 2004.
66. Gersbach, C.A., Byers, B.A., Pavlath, G.K., and Garcia, A.J. Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp. Cell Res. 300, 406, 2004.
67. Hee, C.K., Jonikas, M.A., and Nicoll, S.B. Influence of three-dimensional scaffold on the expression of osteogenic differentiation markers by human dermal fibroblasts. Biomaterials 27, 875, 2006.
68. Chung, C.H., Golub, E.E., Forbes, E., Tokuoka, T., and Shapiro, I.M. Mechanism of action of beta-glycerophosphate on bone cell mineralization. Calcif. Tissue Int. 51, 305, 1992.
69. Boyan, B.D., Schwartz, Z., and Boskey, A.L. The importance of mineral in bone and mineral research. Bone 27, 341, 2000.
70. Cartmell, S.H., Porter, B.D., Garcia, A.J., and Guldberg, R.E. Effects of medium perfusion rate on cell-seeded three-dimensional bone constructs in vitro. Tissue Eng 9, 1197, 2003.
71. Porter, A., Patel, N., Brooks, R., Best, S., Rushton, N., and Bonfield, W. Effect of carbonate substitution on the ultrastructural characteristics of hydroxyapatite implants. J. Mater. Sci. Mater. Med. 16, 899, 2005.
72. Patel, N., Best, S.M., Bonfield, W., Gibson, I.R., Hing, K.A., Damien, E., and Revell, P.A. A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules. J. Mater. Sci. Mater. Med. 13, 1199, 2002.
73. Schepers, E., de Clercq, M., Ducheyne, P., and Khan, S.N. Bioactive glass particulate material as a filler for bone lesions. J. Oral Rehabil. 18, 439, 1991.
74. Klein, C.P.A.T., Dreissen, A.A., de Groot, K., and van den Hooff, A. Biodegradation behavior of various calcium phosphate materials in bone tissue. J. Biomed. Mater. Res. 17, 769, 1983.